{"version":"1.0","provider_name":"South Africa Journal","provider_url":"https:\/\/southafricajournal.com","author_name":"sjadmin","author_url":"https:\/\/southafricajournal.com\/author\/sjadmin-s\/","title":"Johnson &amp; Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV - South Africa Journal","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"vxtUOJ8X2D\"><a href=\"https:\/\/southafricajournal.com\/johnson-johnson-expands-ip-policy-to-create-broad-access-in-128-countries-for-development-of-new-and-optimized-hiv-medicine-formulations-for-children-living-with-hiv\/\">Johnson &amp; Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/southafricajournal.com\/johnson-johnson-expands-ip-policy-to-create-broad-access-in-128-countries-for-development-of-new-and-optimized-hiv-medicine-formulations-for-children-living-with-hiv\/embed\/#?secret=vxtUOJ8X2D\" width=\"600\" height=\"338\" title=\"&#8220;Johnson &amp; Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV&#8221; &#8212; South Africa Journal\" data-secret=\"vxtUOJ8X2D\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"- Expanded Policy will Increase Access for Darunavir Pediatric Formulations in 128 Resource-Limited Countries RARITAN, New Jersey, May 11,&nbsp;2015 \/ PRNewswire &ndash;&nbsp;Johnson &amp; Johnson today announced that its Janssen Pharmaceutical Companies have furthered their commitment to improve the health of children living with HIV through an expanded policy aimed at enhancing access to its HIV [&hellip;]"}